Board
Executive Board
Mr Keith Chantler – Executive Director
Non-Executive Board
Executive Board
Mr Don Hammond – Chairman
Don Hammond is an experienced businessman and has worked
within both the private and public sector. He worked in industry
before studying at Manchester Business School. After completing
his studies, he joined Citibank and then a small London merchant
bank.
After 14 years in the City, he set up a small regional bank in the
mid 1980's raising venture capital from various institutions. This
merged with a Regional firm of stockbrokers in 1988. After a
period as Director of the Corporate Finance team, he became
a business angel and now has investments in a number of
emerging companies. Don was also the Chairman
of Halton Hospital
and then Cheshire Community Trusts.
Mr Keith Chantler – Executive Director
Keith is the Director of Academic Affairs and Innovation at
Central Manchester and Manchester Children’s University Hospitals
NHS Trust. He has regional and national experience in NHS
research and innovation management, and manages the
Trust’s extensive R&D portfolio.
Keith is a founder of TrusTECH, the North West NHS Innovation
Hub, which brings together nearly 70 NHS Trusts (in close
collaboration with the region’s universities) to discover and
exploit bio/health intellectual property in the Northwest.
Non-Executive Board
Dr John Beacham, OBE
John’s experience and expertise are in new product innovation,
science and technology strategy, R&D, and business-higher
education partnerships and Networks. He spent 35 years in the
Chemical and Pharmaceutical Industry where his last post was
Research Manager and Chief Scientist for ICI plc. He was awarded
a CBE in the 2000 New Year’s Honours List “for services to the
Chemical Industry”.
John is Chairman of COGENT the Sector Skills Council for the
Chemical/Oil and Gas/Nuclear Industry, Chairman of University
of Liverpool Enterprises Ltd (ULivE) and a Director of the newly
formed Bioscience for Business Knowledge Transfer Network.
He is also a director of CLIK, the CCLRC exploitation company and,
for the last eight years, has also been an Industrialist/Advisor to the DTI. John is an Honorary Professor at Liverpool and Liverpool John Moores Universities and was awarded a DSc in 2004 by the new University of Manchester for his work on the amalgamation of UMIST/Manchester University. He is currently World President of the Society for the Chemical Industry (SCI).
Mr David Ford
David has both clinical and engineering experience in the biomedical
sector. He is currently a director of Vernon-Carus Limited, where
his primary responsibility is sales and marketing.
He has 20 years’ experience in the medical device industry
(product and licence management, strategic planning, managing
change, systems integration, sales and marketing, research
and development, and personnel development). For the last
10 years, these positions have been at board level and have
involved a number of ‘blue chip’ global medical device companies.
Prior to his industrial experience, he managed a Bio-Engineering
Unit team within an NHS hospital, where he also led the design
of medical and research equipment.
Professor Sir Netar Mallick
Sir Netar Mallick is Professor Emeritus of Renal Medicine in
Manchester. He was knighted in 1998. He demitted office as Medica
l Director of the National Advisory Committee on Clinical Excellence
Awards (2003–2006) after been Medical Director of the Advisory
Committee on Distinction Awards 1999–2003.
From 1967 he worked in the University Department of Medicine in
Manchester as Lecturer then Senior Lecturer in Medicine and was
Associate Director of the Renal Transplantation Unit from its
inception in 1968. From 1973, as Consultant Renal Physician, he
developed an internationally recognised Department of Renal
Medicine integrated with the Transplantation service.
He has been President of the Renal Association of Great Britain and
Ireland and Adviser to Her Majesty's Government on renal disease. He is a Fellow of the Royal College of Physicians (London) and ad personam of the Royal Colleges of Physicians of Edinburgh and of Ireland and of the Royal College of Surgeons of Edinburgh. He has written and lectured widely on renal disease and renal replacement therapy.
Until 2000 he was Medical Director of Central Manchester NHS Trust. He has been President of the Manchester Literary and Philosophical Society and of the Manchester Medical Society.
Dr Kelvin Schneider
After research in atomic physics at Manchester University, Kelvin
joined the nuclear industry in the North West. His 30-year career
started in radiological safety assessment but he subsequently
moved into R&D where his particular interests were firstly
techniques of waste management and then the use of high-power
lasers. Later he moved into operations management but a common
theme and interest was the role of innovation and the processes
which nurture it.
In 2001, he set up and led a spin-off company which designed and
manufactured energy storage systems based on high-speed
flywheels. The company built a world-wide reputation in sectors
as diverse as urban transport, uninterruptible power and
renewable energy. He is now a founder/director of two start-up
companies; one in the field of energy storage and the other aiming to exploit new high temperature superconductors developed in Cambridge University.
Mr Alun Davies
Alun Davies is an independent business advisor and management consultant. He has over 20 years of hands-on commercial experience with early stage and high growth businesses in multiple sectors, including health care, technology, property, professional services and non profit.
Alun's roles have included Chief Executive of Sheffield Orthopaedics Limited, one of the UK's leading independent orthopaedic health care providers, European Managing Director and Vice President of Marketing for Rockliffe, a Californian software company, and Commercial Director of FiLGROUP, a property development company involved in urban regeneration. He is also the Chairman of Leeds-based CASAC, one of the UK's leading social enterprises.